Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter registry study of bivalirudin in Chinese patients with coronary artery disease undergoing PCI
ChiCTR1800016751Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Jun 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bivalirudin in coronary arteriosclerosis, sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Net adverse clinical events. Started Jun 2018; status: recruiting.
02
Drugs
bivalirudin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800016751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016751.